Prostaglandin E1 improves survival rate after 95% hepatectomy in rats. 2008

Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan. togo@med.yokohama-cu.ac.jp

OBJECTIVE Prostaglandin E1 (PGE1) has a wide-ranging effect on cytoprotection. Overproduction of heat shock protein 70 (HSP70) in the liver protects hepatocytes under various pathologic conditions. In this study, we examined the effect of a nontoxic HSP-inducer, PGE1, on acute liver failure after 95% hepatectomy in rats. METHODS PGE1 or vehicle was intravenously administered to rats 30 min before and during hepatectomy. RESULTS Nine of 30 rats pretreated with PGE1 survived, whereas all 20 rats pretreated with vehicle died within 96 h after operation. During the 24-h postoperative period, PGE1 significantly suppressed the release of alanine aminotransferase and elevation of hyaluronic acid. Histological examination showed that the vacuolized hepatocytes and round hepatocytes with pyknotic nuclei are frequently seen in rats pretreated with vehicle, whereas active regeneration is seen in rats pretreated with PGE1. During the first 24 h after surgery, HSP70 induction was absent in the residual livers of vehicle-treated rats. In contrast, PGE1 stimulated the HSP accumulation within 24 h, and viable hepatocytes contained abundant HSP70 in their nuclei. CONCLUSIONS Our results suggest that PGE1 may prevent acute liver failure after massive hepatectomy, at least in part, by enhancing HSP70 production in the residual liver.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006820 Hyaluronic Acid A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA. Amo Vitrax,Amvisc,Biolon,Etamucine,Healon,Hyaluronan,Hyaluronate Sodium,Hyvisc,Luronit,Sodium Hyaluronate,Acid, Hyaluronic,Hyaluronate, Sodium,Vitrax, Amo
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
October 2012, Hepato-gastroenterology,
Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
January 1993, Surgery today,
Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
January 2002, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,
Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
July 1995, Acta dermato-venereologica,
Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
April 2015, The Journal of surgical research,
Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
July 1994, Archives of surgery (Chicago, Ill. : 1960),
Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
October 2002, Hepatology research : the official journal of the Japan Society of Hepatology,
Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
January 1992, British journal of plastic surgery,
Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
December 2001, The Journal of surgical research,
Shinji Togo, and Haochuan Chen, and Takuji Takahashi, and Toru Kubota, and Kenichi Matsuo, and Daisuke Morioka, and Kazuteru Watanabe, and Harumi Yamamoto, and Yoji Nagashima, and Hiroshi Shimada
September 1995, Masui. The Japanese journal of anesthesiology,
Copied contents to your clipboard!